Molecular pathology of macrophages and interleukin-17 in age-related macular degeneration

Chi-Chao Chan1, Daniel Ardeljan

  • 1Section of Immunopathology, Laboratory of Immunology, National Eye Institute, National Institutes of Health, 10 Center Drive, 10/10N103, 20892-1857, Bethesda, MD, USA, chanc@nei.nih.gov.

Insights

Age-related macular degeneration (AMD) involves ocular inflammation, with macrophages and interleukin-17 playing key roles. Targeting these inflammatory pathways may offer new therapeutic strategies for AMD.

Area of Science:

  • Ophthalmology
  • Immunology
  • Pathology

Background:

  • Age-related macular degeneration (AMD) involves the degeneration of photoreceptors, retinal pigment epithelial cells, and choroidal capillaries.
  • Ocular inflammation, particularly in the macula, is a critical factor in AMD pathogenesis, though not a typical uveitis.

Purpose of the Study:

  • To review the role of inflammatory and immune-related elements in AMD pathogenesis.
  • To discuss the deviation in macrophage plasticity and elevated interleukin-17 expression in AMD eyes.

Main Methods:

  • Review of existing literature on ocular inflammation in AMD.
  • Analysis of the role of innate immune system components, including macrophages and cytokines.

Main Results:

  • Innate immune cells like macrophages and secreted cytokines are integral to AMD pathology.
  • Observed deviations in macrophage plasticity and elevated interleukin-17 expression in AMD are noted.

Conclusions:

  • Inflammatory pathways involving macrophages and interleukin-17 are implicated in AMD pathogenesis.
  • Targeting specific inflammatory molecules and pathways presents a promising avenue for novel adjunct therapies for AMD.